Why the study?
Observational studies on the benefit of primary PCI versus conservative management for late-presenting STEMI patients have been inconsistent, and most randomized trials date from the fibrinolytic era.
Does late presentation (12-24 hours) worsen in-hospital and 1-year death risks in STEMI patients compared to earlier presentation?
Does late presentation (12-24 hours) worsen in-hospital and 1-year death risks in STEMI patients compared to earlier presentation?
STEMI patients presenting 12-24 hours after symptom onset have similar in-hospital and 1-year mortality risks compared to earlier presenters, supporting the benefit of primary PCI in this population.
Answers are grounded in this paper and cite their sources.
Comparable mortality despite lower PCI use in late STEMI presenters; observational data leave optimal timing open for prospective trials.
OBJECTIVES: To assess the characteristics and prognosis of ST-elevation myocardial infarction (STEMI) patients, presenting between 12 and 24 h after symptom onset, in contemporary regional STEMI systems of care in the United States. BACKGROUND: Previous observational studies have been inconsistent regarding the benefit of primary percutaneous coronary intervention (PCI) compared with conservative management for late-presenting STEMI patients and the majority of randomized trials are from the fibrinolytic era. METHODS: Using a two-center registry-based cohort from March 2003 to December 2020, we evaluated the frequency, clinical characteristics, and outcomes of STEMI patients, stratified by symptom onset to balloon time: <3, 3-6, 6-12, and 12-24 h (late presenters). RESULTS: Among 5427 STEMI patients with available symptom onset time, 6.2% were late presenters, which increased to 11% during the early phase of the Covid-19 pandemic. As symptom onset to balloon time increased, patients were more likely to be older, female, and have a history of hypertension and diabetes mellitus. Late presenters with an identifiable culprit lesion were less likely to be revascularized with PCI (96%, 96%, 95%, and 92%; p for trend = 0.004) and had a longer median door-to-balloon time (82, 109, 107, and 117 min; p for trend < 0.001). In-hospital and 1-year death risks were comparable between late and earlier presenters. CONCLUSION: Despite the unfavorable risk profile and longer door-to-balloon time, clinical outcomes of late presenters were similar to those presenting within 12 h of symptom onset.
No takes yet. Share an insight, caveat, or question.
Griffin et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: